English
Home > Products > 933779-95-4

China 933779-95-4 Factory

Each individual member from our significant effectiveness gross sales workforce values customers' demands and small business communication for 933779-95-4,CAS NO 933779-95-4,6-Hydroxypurine, We hope we can have a friendly relationship with businessman from all over the world.
933779-95-4, Although continuous opportunity, now we have now developed serious a friendly relationship with many oversea merchants, such as ones through Virginia. We securely assume that the merchandise regarding t shirt printer machine is often good through a great number of having its good quality and also cost.

Related Products

Hot Products

  • (9,9-Dimethyl-9H-fluoren-2,7-diyl)diboronic acid

    (9,9-Dimethyl-9H-fluoren-2,7-diyl)diboronic acid

    Product Name:(9,9-Dimethyl-9H-fluoren-2,7-diyl)diboronic acid
    Molecular Formula:C15H16B2O4
    Molecular Weight:281.91
    CAS Registry Number:866100-14-3
  • Venetoclax

    Venetoclax

    Product Name:Venetoclax
    Molecular Formula:C45H50ClN7O7S
    Molecular Weight:868.44
    CAS Registry Number:1257044-40-8
  • 2,2'-Dithiosalicylic acid

    2,2'-Dithiosalicylic acid

    Product Name:2,2'-Dithiosalicylic acid
    Molecular Formula:C14H10O4S2
    Molecular Weight:306.36
    CAS Registry Number:119-80-2
  • Bepotastine Besilate

    Bepotastine Besilate

    Product Name:Bepotastine Besilate
    Molecular Formula:C27H31ClN2O6S
    Molecular Weight;547.06
    CAS Registry Number;190786-44-8
  • Cetrorelix acetate

    Cetrorelix acetate

    Product Name:Cetrorelix acetate
    Molecular Formula:C70H92ClN17O14
    Molecular Weight;1431.04
    CAS Registry Number;120287-85-6/130143-01-0
  • MonoMethyl auristatin E

    MonoMethyl auristatin E

    Product Name:MonoMethyl auristatin E
    Molecular Formula:C39H67N5O7
    Molecular Weight;717.98
    CAS Registry Number;474645-27-7
  • Related Blog
  • Reviews

  • Caffeine CAS No.58-08-2

    Caffeine (CAS No.58-08-2) is a xanthine alkaloid compound, a central nervous stimulant that temporarily drives away drowsiness and restores energy, and is used clinically to treat neurosis and coma recovery. Caffeinated coffee, tea, soft drinks and energy drinks are very popular, so caffeine is also the most commonly used psychotropic drug in the world.

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    Here are so many diseases that affect the human population in the current hours and so are the numerous drugs that are available to treat those diseases.

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications. Our products are produced under strict procedures and cGMP (Current Good Manufacturing Practices). In addtion, we can also customize new pharmaceutical compounds for new drugs.

  • How much do you know about minocycline hydrochloride?

    Minocycline hydrochloride is commonly used as its hydrochloride, which is yellow crystalline powder, odorless, bitter in taste, and can cause deterioration when exposed to light. Soluble in water, slightly soluble in ethanol, easily soluble in alkali metal hydroxide or carbonate solution.

  • Gilteritinib Fumarate

    Sandoo Pharmaceutica is a professional pharmaceutical intermediates manufacturer. We provide good quality Gilteritinib Fumarate Cas: 1254053-43-4. Welcome and we look forward to your inquiry!

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Related Search

CAS NO 933779-95-4

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept